about
Increased neutrophil respiratory burst in bcr-null mutantsSpectral imaging microscopy web sites and data.Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis.β-globin gene transfer to human bone marrow for sickle cell disease.Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia majorNutritional deficiencies in iron overloaded patients with hemoglobinopathiesMRI detects myocardial iron in the human heart.Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens.Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.Sickle cell disease: selected aspects of pathophysiology.Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients.Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia.Systematic review of transition from adolescent to adult care in patients with sickle cell disease.Prediabetes, elevated iron and all-cause mortality: a cohort study.Pulmonary hypertension in well-transfused thalassemia major patientsA practical approach to neutrophil disorders.Pulmonary function in thalassaemia major and its correlation with body iron storesLong-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.Peripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease.A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.Sickle cell disease in California: sociodemographic predictors of emergency department utilizationElectrocardiographic consequences of cardiac iron overload in thalassemia major.MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patientsChronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.Increased leucocyte apoptosis in transfused β-thalassaemia patients.Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis.Physiology and pathophysiology of iron in hemoglobin-associated diseases.The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome.Pancreatic iron loading predicts cardiac iron loading in thalassemia major.Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion.Iron toxicity and its possible association with treatment of Cancer: lessons from hemoglobinopathies and rare, transfusion-dependent anemias.Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?Iron chelation in thalassemia: time to reconsider our comfort zones.Angiomatoid malignant fibrous histiocytoma with extensive lymphadenopathy simulating Castleman's disease.
P50
Q28506764-BE0EA21D-436C-4C05-BC01-0A45249F1A69Q33257394-417D3F80-EF04-4E10-B010-26CC655BDBA3Q33369066-6C97D71A-1C19-4F5D-9CEC-18FA18B48683Q33570348-74A9594B-6E04-4B22-A7A7-E3CFF139879BQ33909056-E897B466-17CB-4E7D-B7E9-272F86BE2531Q33920971-1787C51B-2E0A-450C-96CE-3C21C36B988AQ33920978-37EFABC0-2520-4FD8-A899-35284E4667D2Q33921092-E18256CA-6ACA-45C1-A68A-CCCA4D16831DQ33944316-4A6745E9-5F3B-4867-AE86-1F468467AAA8Q33958448-2973B004-A66B-414B-959B-E9A492F19ABAQ34004503-12B16035-F355-4E6E-A320-C09797FAFEC8Q34023071-6C928550-3553-4001-A41E-3DD96BFF3B66Q34052649-B5DC119C-4D4F-43BA-8B9A-9BDDBA05EAF4Q34205726-4E0CD8B6-3650-41D9-BC63-2C58B2C1CEC9Q34627981-FC62A7D6-EB1B-47D3-9151-F1736E982A36Q34692388-DA69DB37-CBCF-4037-AE89-79F27288344EQ34979478-569F2FFB-819C-4428-9B98-F2FFE8448B0AQ34995959-CDC813AD-EE98-47C7-9EA8-19FC4D937246Q35204631-E51CD445-F2BD-41AF-BBBD-C36A22B5A305Q35206809-F9FF8F9B-3D7F-43F6-A20C-66E0D20AF65BQ35219737-EAD16004-9F54-4065-9929-6C8B9BD701BAQ35367747-8AD1DA65-4B47-4B4A-B852-FEAC8FF9034EQ35735978-8D9CE8FD-6226-4A60-B49F-DF46EF17289EQ35836446-BCDED203-DA1B-4CD3-B5DD-0DF567A56273Q35848072-BE02F042-F905-4B74-BACC-4BA34BAEB7D5Q35925616-64F88943-7EB6-4FF0-BFF2-3CB5F35495FCQ35987342-FD38309F-D2E0-45CB-A0FC-4ABC960402B8Q36136232-97E13C54-E605-4B7F-8989-2170C62B3BD0Q36777811-6C9C965C-C0A0-46B7-A1BF-EFB1208DCBEAQ36946007-33C4FC33-0D78-4A8B-8BB3-AFB7EEBA1F63Q37002706-699559A3-2B3C-413E-8509-33E636A3D826Q37082896-98B0862C-9339-47B5-82B6-E80CE3C2945FQ37189237-20A28961-1C86-4CF5-BB39-E4B58E806ACEQ37414689-08350D6F-5A9E-47CE-8E6B-68B4BBCE0E21Q37427974-3A976EC9-6D49-4BDF-A53B-42214635DC7EQ37643049-1BB48A03-22F0-470A-A4F3-9A10A1E3FC15Q38281071-78A91E30-7CCA-439B-ADD7-CBCE4A3B0457Q38836181-5DD71745-18D6-4DEE-AC30-9B4885008D21Q39782885-339B8F76-8E68-4515-87BB-4756A5627AB8Q40812810-1851D314-286D-4DCB-90F5-32BA342DFEC1
P50
description
chercheur
@fr
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Coates
@af
Thomas Coates
@an
Thomas Coates
@ast
Thomas Coates
@bar
Thomas Coates
@br
Thomas Coates
@ca
Thomas Coates
@co
Thomas Coates
@cs
Thomas Coates
@cy
Thomas Coates
@da
type
label
Thomas Coates
@af
Thomas Coates
@an
Thomas Coates
@ast
Thomas Coates
@bar
Thomas Coates
@br
Thomas Coates
@ca
Thomas Coates
@co
Thomas Coates
@cs
Thomas Coates
@cy
Thomas Coates
@da
prefLabel
Thomas Coates
@af
Thomas Coates
@an
Thomas Coates
@ast
Thomas Coates
@bar
Thomas Coates
@br
Thomas Coates
@ca
Thomas Coates
@co
Thomas Coates
@cs
Thomas Coates
@cy
Thomas Coates
@da
P106
P1153
56059750800
P21
P31
P496
0000-0001-9878-6029